Drugs Made In America Acquisition Corp Stock (DMAA) Price History
The historical daily chart and data for Drugs Made In America Acquisition Corp stock (DMAA), show that the latest closing stock price as of November 10, 2026, is $10.90.
- Drugs Made In America Acquisition Corp all-time high stock price is $10.90, occurred on November 10, 2026.
- The lowest Drugs Made In America Acquisition Corp stock price recorded was $9.96 on February 27, 2025. Since then, Drugs Made In America Acquisition Corp's stock price has risen over 8.62% to $10.90 now.
- The 52-week high stock price for DMAA is $10.90, representing a 0.00% increase from the current share price, occurred on November 10, 2026.
- The 52-week low stock price for DMAA is $10.31, indicating a 5.41% decrease from the current share price, occurred on November 13, 2025.
- The closing price of Drugs Made In America Acquisition Corp (DMAA) stock in the beginning of 2025 was $9.96. The stock closed the year at $10.37, a gain of over 4.16% for the year.
The table below shows more information about DMAA historical price data:
Drugs Made In America Acquisition Corp Stock (DMAA) Year by Year Price History
In this detailed analysis, we present a comprehensive overview of the price movements of Drugs Made In America Acquisition Corp stock over the years. By exploring the year-by-year data, investors can gain valuable insights into the historical performance and volatility of DMAA shares. From significant milestones and fluctuations to notable trends, this in-depth examination of Drugs Made In America Acquisition Corp stock price history provides a foundation for understanding how the company's stock has evolved over time.